v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 6,304 $ 12,226
Accounts receivable 18  
Research and development tax credit receivable 738 1,070
Prepaid expenses and other current assets 1,426 802
Total current assets 8,486 14,098
Property, plant equipment, net of accumulated depreciation of $1,019 and $1,102 584 802
Right-of-use assets, net 495 154
Other assets 6 6
Total assets 9,571 15,060
LIABILITIES AND STOCKHOLDERS' EQUITY    
Accounts payable and accrued expenses 1,215 1,423
Current lease liabilities 199 87
Total current liabilities 1,414 1,510
Non-current lease liabilities 275 28
Total liabilities 1,689 1,538
Commitments and contingencies (Note 8)
Stockholders' Equity:    
Common stock, par value $0.0001 per share, 300,000,000 shares authorized, 26,949,282 and 25,554,309 shares issued and outstanding, at September 30, 2022 and December 31, 2021, respectively 3 3
Additional paid-in capital 92,735 89,954
Accumulated other comprehensive loss 632 (1,363)
Accumulated deficit (85,488) (75,072)
Total stockholders' equity 7,882 13,522
Total Liabilities and Stockholders' Equity $ 9,571 $ 15,060

Source

PDF HTML 10-Q Filing
ZIP XLS HTML XBRL